Patents for C12P 21 - Preparation of peptides or proteins (112,499)
07/2011
07/26/2011US7985841 Heterodimeric receptor libraries using phagemids
07/26/2011US7985835 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
07/26/2011US7985571 Isolated genomic polynucleotide fragments from chromosome 17 that encode human carboxypeptidase D
07/26/2011US7985564 Expression systems with sec-system secretion
07/26/2011US7985411 Activatable recombinant neurotoxins
07/26/2011US7985407 Method of treating solid tumor
07/26/2011CA2461571C Muteins of human neutrophil gelatinase-associated lipocalin and related proteins
07/26/2011CA2453528C Novel fusion proteins and assays for molecular binding
07/26/2011CA2432995C Immunogenic hla-a2 supermotif-restricted peptides
07/26/2011CA2411249C Gasc1 gene
07/26/2011CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
07/26/2011CA2289912C Human receptor proteins; related reagents and methods
07/26/2011CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
07/26/2011CA2215350C Transforming growth factor alpha hii
07/26/2011CA2213340C Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
07/21/2011WO2011088111A1 ANTI-PlGF ANTIBODIES AND METHODS USING SAME
07/21/2011WO2011087627A1 Stabilized interferon formulations
07/21/2011WO2011087092A1 Anti-influenza antibody and influenza detection device
07/21/2011WO2011087091A1 Anti-asct2 (system asc amino acid transporter type 2) antibody
07/21/2011WO2011086973A1 Antibody specific to activated egfr
07/21/2011WO2011086589A1 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field
07/21/2011WO2011086141A1 Bacterial host strain expressing recombinant dsbc
07/21/2011WO2011086138A1 Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene
07/21/2011WO2011085602A1 Protein hydrolysate, polypeptide solution and polypeptide, preparation method and use thereof
07/21/2011WO2011062926A3 Methods for enhanced protein production
07/21/2011US20110179503 Protein production in a host
07/21/2011US20110178182 Enriched nanostructure composition
07/21/2011US20110178029 Modified Human Apolipoprotein A-1 and Their Uses
07/21/2011US20110178026 Ricin-like toxins for treatment of cancer
07/21/2011US20110177997 Cross-Beta Silk Genes
07/21/2011US20110177615 Protein expression
07/21/2011US20110177611 Ligand binding domains of nuclear receptors in controllable form and methods involving the same
07/21/2011US20110177557 Fusion Protein and Use Thereof
07/21/2011US20110177556 Nucleic Acids Encoding Chimeric CD154 Polypeptides
07/21/2011US20110177555 Chinese hamster ovary cell lines
07/21/2011US20110177554 Secreted frizzled related protein, sfrp, fragments and methods of use thereof
07/21/2011US20110177553 Preparation of an esterase
07/21/2011US20110177552 Systems and methods for producing plastid proteins
07/21/2011US20110177524 Recombinant Fibrinogen
07/21/2011US20110177522 Methods for Producing Olfactory GPCRs
07/21/2011US20110177498 Base-detecting pore
07/21/2011US20110177132 Compositions and Methods for Generating Musculoskeletal Tissue
07/21/2011US20110177095 Anti-her2 antibodies and their uses
07/21/2011US20110177087 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse
07/21/2011US20110177085 Bitter Taste Receptors
07/21/2011US20110177074 Compositions and methods for inhibiting pdgfrbeta and vegf-a
07/21/2011US20110177073 Recombinant production of mixtures of antibodies
07/21/2011US20110177070 TGF-Beta Antagonist Multi-Target Binding Proteins
07/21/2011US20110177029 O-linked glycosylation using n-acetylglucosaminyl transferases
07/21/2011CA2786745A1 Wnt-binding agents and uses thereof
07/21/2011CA2785931A1 Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene
07/21/2011CA2785634A1 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field
07/21/2011CA2785212A1 Novel bacillus thuringiensis gene with coleopteran activity
07/20/2011EP2345734A2 Fermentative production of valuable compounds on an industrial scale using chemically defined media
07/20/2011EP2345728A1 Yeast membrane protein expression system and its application in drug screening
07/20/2011EP2345724A1 G-CSF analog compositions and methods
07/20/2011EP2345721A1 Recombinant gelatin in vaccines
07/20/2011EP2345424A1 CD4-specific antibody TRX1 and uses therefor
07/20/2011EP2344524A2 Kit for the optimisation of protein synthesis/secretion
07/20/2011EP2142563B1 Bis-met histones
07/20/2011EP1712564B1 Anti-nc1 monoclonal antibody
07/20/2011EP1545613B1 Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
07/20/2011EP1373477B1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
07/20/2011EP1274318B1 Cultured protein hydrolysate
07/20/2011EP1181317B1 An integrin heterodimer and an alpha subunit thereof
07/20/2011EP1157043B1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
07/20/2011EP1053256B1 Antibodies to death receptor 4 (dr4) and uses thereof
07/20/2011CN1993469B Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof
07/20/2011CN102131524A Monoclonal antibodies to fibroblast growth factor receptor 2
07/20/2011CN102127580A Technique for extracting ACE (angiotensin-converting enzyme) inhibitory peptide by carrying out enzymolysis on mussels
07/20/2011CN102127579A Preparation process of mixed milk peptide
07/20/2011CN102127578A Method for producing pediococcusacidilactici by accumulation
07/20/2011CN102127564A Construction of NGAL (neutrophil gelatinase-associated lipocalin) plasmid, and expression of fusion protein of NGAL plasmid
07/20/2011CN102127562A Seed specificity expression vector, construction method and applications thereof
07/20/2011CN102127552A CPTI (Cowpea Trypsin Inhibitor) gene, applications thereof and method for preparing great amount of CPTI
07/20/2011CN102127533A Preparation method of recombinant porcine circovirus type 2 Cap antigen
07/20/2011CN102127531A Korean novel duck hepatitis viral antibody ELISA (Enzyme-Linked Immunosorbent Assay) detection kit
07/20/2011CN102127523A Hybridoma cell line and application thereof
07/20/2011CN102127167A Whole human TNF alpha (tumor necrosis factor alpha) monoclonal antibody and preparation and application thereof
07/20/2011CN102127160A Scorpion active polypeptides as well as preparation method and application thereof
07/20/2011CN102127157A Mitochondrion RNA polymerase subsidiary transcription factor as well as polymerase-transcription factor compound and application thereof
07/20/2011CN101544976B Bidirectional promoter bi-visual fluorescent protein report gene plant expression vector
07/20/2011CN101463362B Expression vector for fusion expression of green fluorescent protein, construction method and use thereof
07/20/2011CN101463361B Expression vector of double expression boxes, as well as preparation method and application thereof
07/20/2011CN101411405B Insect tissue zymolyte and use thereof in artificial culture of entomopathogenic nematodes
07/20/2011CN101381759B Preparation method of buckwheat protein biological activity peptides
07/20/2011CN101255454B Method for biosynthesis of glutathione by using yeast
07/20/2011CN101250573B Method for inducing phytophthora infestans to produce pathogenic secretory protein
07/20/2011CN101230375B Jellyfish originated glycoprotein having fatigue resistant activity and preparation technique thereof
07/20/2011CN101065402B Process for obtaining antibodies
07/19/2011US7982024 Antibodies to insulin-like growth factor I receptor
07/19/2011US7982017 Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
07/19/2011US7982015 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders
07/19/2011US7982013 Frizzled-binding agents and uses thereof
07/19/2011US7982012 Compositions and methods for the therapy and diagnosis of cytomegalovirus
07/19/2011US7982011 Mutated anti-cd22 antibodies and immunoconjugates
07/19/2011US7982007 Cynomolgus toll-like receptor 3
07/19/2011US7981844 Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes
07/19/2011US7981843 Antibody specificity transfer using minimal essential binding determinants
07/19/2011US7981675 LITAF binding site peptides and methods of using the same